Here are the DEF 14A proxy statements from Outset Medical, Inc. (OM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow OM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OM filings page.
Outset Medical, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on June 4, 2026 at 1:30 p.m. Pacific Time. Holders of 18,529,233 common shares as of April 9, 2026 may vote on electing two Class III directors, an advisory say‑on‑pay resolution, and ratifying KPMG LLP as independent auditor for 2026.
The company highlights 2025 net revenue of $119.5 million, 6% growth in recurring revenue to $88.7 million, and gross margin of 39.1% (39.6% non‑GAAP). It also describes board structure, governance practices, stock ownership and recoupment policies, and an executive pay program that mixes salary, annual bonuses and performance‑based equity.